Monthly Archives: May 2012

Reducing TB transmission in ‘hotspots’ could have widespread benefit

By on .

In a recent study published in the journal PNAS, researchers at the Johns Hopkins Bloomberg School of Public Health discovered that public health efforts to reduce tuberculosis transmission in geographic “hotspots” where infections are highest could significantly reduce TB transmission on a broader scale. Researchers analyzed surveillance data from Rio de Janeiro and developed mathematical […]

New developments in HIV research, South African Children affected by HIV, and more

By on .

The following list of What We’re Reading is a compilation of recent releases and reports making headlines in global health: Implementing Collaborative TB-HIV Activities – A Programmatic Guide: This guide from the International Union Against Tuberculosis and Lung Disease summarizes The Union’s experience in developing approaches to integrated TB-HIV care for adults in resource-limited settings. […]

U.S. opposes proposed international org for R&D to meet the health needs of developing countries

By on .

At the World Health Assembly in Geneva this week, representatives are debating whether or not to create a new international organization that would bind countries to fund research and development, or R&D, for neglected diseases – to which every nation would commit to spend at least .01 percent of gross domestic product (GDP) on government-funded […]

Beginning to End the AIDS Epidemic: What’s the Research Agenda?

By on .

Capitol Hill briefing highlights research agenda to end AIDS

The following is a guest blog post by Chris Collins, vice president and director of Public Policy at the Foundation for AIDS Research (amfAR) and Mitchell Warren, executive director of AVAC.

Looking back over three decades of AIDS, it’s hard to point to a better investment than research. Over the past three years, a string of HIV prevention research breakthroughs has put the ambitious goal of even talking about an end of AIDS within sight for the first time. With more strategic use of the tools we have today, we can bend the curve of new infections…

Breaking News: Senate subcommittee votes to boost funding for Global Fund and global TB in 2013

By on .

The Senate Appropriations Subcommittee on State and Foreign Operations voted Tuesday on its funding bill for global health and foreign assistance programs beginning Oct. 1, 2012.  The committee voted to fund the Global Fund to fight AIDS, Tuberculosis and Malaria at the president’s budget request of $1.65 billion – which would fulfill the U.S. four-year, […]

New HIV vaccine trial begins recruiting U.S. participants

By on .

The National Institutes of Health (NIH)-funded HIV Vaccine Trials Network (HVTN) has started enrolling participants in a Phase 1 clinical trial to test a “second-generation” HIV vaccine candidate, meaning the vaccine is identical to the first generation candidate but it includes a special additive to enhance the vaccine response. The additive, or adjuvant, is granulocyte-macrophage […]

Does global health spending make a difference? Americans on both sides of the aisle say: Yes!

By on .

The U.S. is spending too little or about the right amount on global health aid, according to two-thirds of Americans surveyed recently by the Kaiser Family Foundation (KFF), with one in five saying the U.S. spends too much. Overall the majority of Americans surveyed believes the U.S. has a major role to play in the […]

Anthony Fauci Makes Statement on HIV Vaccine Awareness Day

By on .

The following is a statement on HIV Vaccine Awareness Day from Anthony Fauci, MD, Director of National Institute of Allergy and Infectious Diseases of the National Institutes of Health.  It was originally published here.  There is a growing consensus that we can significantly curtail the HIV/AIDS pandemic by implementing scientifically proven HIV prevention strategies, such as voluntary […]

Modeling Potential Impact on HIV Vaccine Awareness Day

By on .

The following guest blog post in honor of HIV Vaccine Awareness Day was written by Margaret McGlynn, IAVI President and CEO.  It originally appeared on USAID’s Impact blog. Throughout my career, I have witnessed the tremendous power of vaccines to prevent sickness and save lives – delivering incredible victories for humanity against diseases such as polio, […]